Legochnyy gistiotsitoz X - sovremennye predstavleniya, diagnostika i taktika lecheniya


Cite item

Full Text

References

  1. Nicholson H. N., Lukens J. N. Langerhans cell histiocytosis. In: Lee G. R., Foerster J., Lukens J. et al., eds. Wintrobe's clinical hematology. 10,h ed. Baltimore: Williams & Wilkins; 1999. 1916-1926.
  2. Tazi A., Soler P., Hance A. J. Adult pulmonary Langerhans cell histiocytosis. Thorax 2000; 55: 405-417.
  3. Kannourakis G., Abbas A. The role of cytokines in the pathogenesis of Langerhans cell histiocytosis. Br. J. Cancer 1994; 70; S37-S40.
  4. Asakura S., Colby T. V., Limper A. H. Tissue localization of transforming growth factor-beta in pulmonary eosinophilic granuloma. Am. J. Respir. Crit. Care Med. 1996; 154: 1525- 1530.
  5. Hayashi Т., Rush W. L., Travis W. D. et al. Immunohistochemical study of matrix metalloproteinases and their tissue inhibitors in pulmonary Langerhans cell granulomatosis. Arch. Pathol. Lab. Med. 1997; 121: 930-937.
  6. Geissmann F., Lepelletier Y., Fraitag S. et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 2001; 1 (5): 1241-1248.
  7. Bansal D., Marwaha R. K., Trehan A. et al. Portal hypertension secondary to Langerhans cell histiocytosis. Indian J. Gastroenterol. 2001; 20: 201-202.
  8. Melendez H. V., Dhawan A., Mieli-Vergani G. et al. Liver transplantation for Langerhans cell histiocytosis: a case report and literature review. Transplantation 1996; 62: 1167-1195.
  9. Gaensler E. A., Carrington С. В. Open biopsy for chronic infiltrative lung disease: clinical, roentgenographic and physiological correlations in 502 patients. Ann. Trorac. Surg. 1980; 30: 411-426.
  10. Watanabe R., Tatsumi K., Hashimoto S. Clinico-epidemiological features of pulmonary histiocytosis X. Intern. Med. 2001; 40: 999-1003.
  11. Hance A. J., Basset F., Saumon G. et al. Smoking and interstitial lung disease. Ann. N. Y. Acad. Sci. 1986; 465: 643-656.
  12. Travis W. D., Borok Z., Roum J. H. et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 cases. Am. J. Surg Pathol. 1993; 17: 971-986.
  13. Knight R. K. Haemoptysis in eosinophilic granuloma. Br. J. Dis. Chest 1979; 73: 181-186.
  14. Scholfeld N., Frank W., Wenig S. et al. Clinical and radiological features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration 1993; 60: 38-44.
  15. Soler P., Bergeron A., Kamboucher M. et al. Is high-resolution computed tomography a reliable tool to predict the histopathological activity of pulmonary Langerhans cell histiocytosis. Am. J. Respir. Crit. Care Med. 2000; 162: 264-270.
  16. Crausman R. S., Jennings С. A., Tuder R. M. et al. Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Ibid. 1996; 153: 426-435.
  17. Houssini I., Tomashefski J. F., Cohen A. et al. Transbronchial biopsy in patients with pulmonary eosinophilic granuloma. Arch. Pathol. Lab. Med. 1994: 118: 523-530.
  18. Minghini A., Trogdon S. D. Recurrent spontaneous pneumothorax in pulmonary histiocytosis X. Am. Surg. 1998; 64: 1040- 1042.
  19. Murakawa Т., Nakajima J., Kohno T. et al. Pulmonary eosinophilic granuloma associated with recurrent pneumothorax: report of a case. Kyobu Geka 2000; 53 (suppl. 8): 709-714.
  20. Delobbe A., Durieu J., Duhamel A. et al. Determinants of survival in pulmonary Langerhans cell granulomatosis (histiocytosis X). Eur. Respir. J. 1996; 9: 2002-2006.
  21. Mizutani H., Horiba M., Shindoh J. et al. A case of pulmonary eosinophilic granuloma arising rapidly 30 years after the start of smoking and remitting spontaneously without smoking cessation. Nihon Kokyuki Gakkai Zasshi 2001; 39: 852-856.
  22. Minkov M., Grois N., Heitger A. et al. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. Klin. Paediatr. 2000; 212: 139-144.
  23. Akcay S., Eyboglu F. O., Arican A., Demirhan B. Effect of pulse steroid therapy in a patient with Langerhans cell histiocytosis. Respirology 2001; 6: 357-360.
  24. Benyones В., Crestani В., Couvelard A. et al. Steroid-responsive pulmonary hypertension in a patient with Langerhans cell granulomatosis (histiocytosis X). Chest 1996; 110: 284-286.
  25. Minkov M., Grois N., Broadbent V. et al. Cyclosporine A therapy for multisystem Langerhans cell histiocytosis. Med. Pediatr. Oncol. 1999; 33: 482-485.
  26. Lancaster Т., Stead L., Silagy С. et al. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. Br. Med. J. 2000; 321: 355-358.
  27. Etienne В., Bertochi M., Gamondes J.-P. et al. Relapsing pulmonary Langerhans cell histiocytosis after lung transplantation. Am. J. Respir. Crit. Care Med. 1998; 157: 288-291.
  28. Gabbay E., Dark J. H., Aschcroft T. et al. Recurrence of Langerhans cell granulomatosis following lung transplantation. Thorax 1998; 53: 326-327.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2003 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies